menu
    • menu

    Company profile for CNX Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CNX is a specialty pharmaceutical company committed to improving the lives of patients with neurological and psychiatric disorders. Guided by strong Environmental, Social, and Governance (ESG) principles, CNX focuses on providing innovative treatments for these complex conditions, as well as essential medicines used in hospital settings. Their dedication to patient care and responsible business practices drives their mission t...
    CNX is a specialty pharmaceutical company committed to improving the lives of patients with neurological and psychiatric disorders. Guided by strong Environmental, Social, and Governance (ESG) principles, CNX focuses on providing innovative treatments for these complex conditions, as well as essential medicines used in hospital settings. Their dedication to patient care and responsible business practices drives their mission to make a meaningful impact on global healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CNX Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    LABS House 15-19 Bloomsbury Way London, WC1A 2TH
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cnx-therapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CNX Therapeutics Wins Two Awards In Two Nights At CPHI Frankfurt
    CNX Therapeutics Wins Two Awards In Two Nights At CPHI Frankfurt

    30 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-30/cnx-therapeutics-wins-two-awards-in-two-nights-at-cphi-frankfurt

    PHARMIWEB
    30 Oct 2025
    Share Share
    CNX Therapeutics Bags 2025 Pharma Industry CSR Programme Award
    CNX Therapeutics Bags 2025 Pharma Industry CSR Programme Award

    11 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-11/cnx-therapeutics-wins-csr-programme-of-the-year-at-2025-pharma-industry-awards

    PHARMAWEB
    11 Sep 2025
    Share Share
    Er-Kim, CNX Deal to Distribute Oncology Products in CEE, Turkey
    Er-Kim, CNX Deal to Distribute Oncology Products in CEE, Turkey

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139051/0/en/Er-Kim-Announces-Exclusive-Agreement-with-CNX-Therapeutics-to-Distribute-Oncology-Products-Across-CEE-and-Turkey.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    CNX Therapeutics Names Peter Butterfield as COO
    CNX Therapeutics Names Peter Butterfield as COO

    25 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-25/cnx-therapeutics-appoints-peter-butterfield-as-chief-operating-officer

    PHARMAWEB
    25 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search